| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |